BMY Bristol-Myers Squibb Co.

50.570.50 (+1.00%)
Close: September 20, 2019

51.100.53 (+1.05%)
Pre-market

Quote

Previous Close
$50.57
Day Range
$49.99-$50.86
52 Week Range
$42.48-$63.69
Volume
13,501,748
Avg Volume
9,714,290
Dividend TTM
$1.63 (3.22%)
Ex-Dividend Date
2019-10-03

Valuation

Market Cap
$82.72B
Enterprise Value (EV)
$81.19B
PE Ratio
13.27
EV/EBITDA
11.44
Price/Sales
3.67
Price/Book
5.90
PEG Ratio
0.79

Financials

Revenue
$22.56B
Gross Profit
$16.08B
EBITDA
$7.10B
EPS, ttm
$3.81
Profit Margin
21.81%
Revenue/Employee
$968.28K
Next Earnings Date
10/31/2019 (39 days)
Debt to Equity
52%
Debt
$7.35B
Cash
$8.88B
Net Debt
-

Performance

Beta
0.86
200 Day Moving Avg
$48.04
50 Day Moving Avg
$46.78
52 Week Change
-18.76%
YTD Change
-2.55%
1 Month Change
5.86%
3 Month Change
2.49%
6 Month Change
3.37%
1 Year Change
-18.76%
2 Year Change
-12.45%
5 Year Change
-5.26%

Share Count

Shares Outstanding
1.6B
Float
1.6B
Restricted Shares
2.1M
Restricted Shares, %
0.13%

Bristol-Myers Squibb Co. Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Giovanni Caforio

Website: http://www.bms.com

Description: Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Employees: 23,300